This is a review of hypnotic drug risks and benefits, reassessing and updating advice presented to the Commissioner of the Food and Drug Administration (United States FDA). Almost every month, new information appears about the risks of hypnotics (sleeping pills). The most important risks of hypnotics include excess mortality, especially overdose deaths, quiet deaths at night, infections, cancer, depression and suicide, automobile crashes, falls, and other accidents, and hypnotic-withdrawal insomnia. Short-term use of one-two prescriptions is associated with greater risk per dose than long-term use. Hypnotics have usually been prescribed without approved indication, most often with specific contraindications, but even when indicated, there is little or no benefit. The recommended doses objectively increase sleep little if at all, daytime performance is often made worse, not better, and the lack of general health benefits is commonly misrepresented in advertising. Treatments such as the cognitive behavioral treatment of insomnia and bright light treatment of circadian rhythm disorders offer safer and more effective alternative approaches to insomnia.
- Toronto Man Leaves Heart-Wrenching Suicide Letter Naming Ativan as Murderer After Suffering Benzodiazepine Withdrawal Syndrome for 3 Years
- 1983 New York Study Shows Diazepam (Valium) No Better Than Placebo For Treatment of “Neurotic” Anxiety
- Why Currently Available Benzodiazepine Dosages Prevent Safe Withdrawal
- Worldwide Call to Action!
- A response to columnist Dr. Greg Smith at the Aiken Standard: Part 5 and End of Series
- Toronto Man Leaves Heart-Wrenching Suicide Letter Naming Ativan as Murderer After Suffering Benzodiazepine Withdrawal Syndrome for 3 Years on
- What is a Low Dose Benzodiazepine? on
- An Update To My Open Letter: The Suffering of a Physician with Benzodiazepine Withdrawal Syndrome and a Call to Fight on
- An Open Letter: Cardiologist and Cancer Survivor Speaks Out on Dangers of Benzodiazepines, and Her Personal Withdrawal Story on
- Why Currently Available Benzodiazepine Dosages Prevent Safe Withdrawal on